Marguerite M Kay

Title: Marguerite M Kay: Innovator in Synthetic Senescent Cell Antigens

Introduction

Marguerite M Kay is a notable inventor based in Temple, TX (US). She has made significant contributions to the field of immunology through her innovative work on synthetic senescent cell antigens. Her research focuses on understanding cellular aging and autoimmune mechanisms, which has important implications for medical diagnostics and treatments.

Latest Patents

Marguerite M Kay holds one patent titled "Synthetic Senescent Cell Antigen." This patent discloses a synthetic senescent cell antigen comprised of purified peptides that are immunoreactive with antibodies to the naturally occurring antigen. The synthetic senescent cell antigen includes two specific peptides with the amino acid sequences SKLIKIFQDHPLQKTYN and LFKPPKYHPDVPYVKR. These peptides can be utilized in various applications, including compositions, diagnostic kits, and methods for detecting or measuring antibodies to senescent cell antigens. Additionally, they can aid in studying cellular aging, separating anions from gases or liquids, and treating certain diseases.

Career Highlights

Marguerite M Kay has established herself as a prominent figure in her field. Her work at Research Corporation Technologies, Inc. has allowed her to explore innovative solutions in immunology. Her research has the potential to advance our understanding of aging and autoimmune diseases, making her contributions invaluable.

Collaborations

Marguerite collaborates with John Jacob Marchalonis, a fellow researcher. Their partnership enhances the scope and impact of their research endeavors.

Conclusion

Marguerite M Kay's work on synthetic senescent cell antigens represents a significant advancement in immunology. Her innovative research has the potential to lead to breakthroughs in diagnostics and treatments for various diseases.